Overview and clinical application of propylthiouracil

Propylthiouracil (PTU) is aantithyroid drugs, mainly used to treatHyperthyroidism (hyperthyroidism), works by inhibiting the synthesis of thyroid hormones. Its core content includesPharmacological mechanism, indications, usage and dosage, adverse reactions and precautions, of which pharmacological mechanisms and clinical applications are the focus. The secondary content involves manufacturers, drug comparisons, and medication recommendations for special populations. The following will be developed in layers to ensure that the information is comprehensive and easy to understand.

Pharmacological mechanisms and indications

propylthiouracil passedInhibit thyroid peroxidase, blocks the synthesis of thyroid hormones (T3, T4), thereby alleviating the symptoms of hyperthyroidism. It can also inhibit the conversion of T4 to the more active T3 in peripheral tissues and is suitable forGraves' disease, thyroid storm and preoperative preparation. Compared with other antithyroid drugs (such as methimazole), PTU has a faster onset of action, but has a higher risk of liver toxicity, so it needs to be selected with caution. In clinical practice, we usually start with a small dose and adjust the medication regimen according to the condition.

Usage, dosage and adverse reactions

The initial dose for adults is usually100-150mg/time, 3 times a day, and gradually reduce the dose after symptoms are controlled. Children need to adjust dosage according to body weight. Common adverse reactions includeRash, arthralgia, neutropenia, and liver damage, it may cause liver failure in severe cases, and liver function needs to be monitored regularly. Pregnant and lactating women should use it under the guidance of a doctor to avoid affecting the fetus or baby. It is necessary to avoid foods high in iodine while taking the medicine to prevent it from affecting the efficacy of the medicine.

Manufacturer and drug comparison

Domestic manufacturers of propylthiouracil includeShanghai Fosun Pharmaceutical, Guangzhou Baiyunshan Pharmaceuticaletc., the common trade name is "propylthiouracil tablets". Compared with methimazole, PTU is more suitable for thyroid storm and early pregnancy (methhimazole may be teratogenic), but it is less safe for long-term use. The following table lists the main differences between the two drugs:

Summary and Notes

Propylthiouracil is an important drug in the treatment of hyperthyroidism, but it must be strictly followedPrinciples of personalized medicine, be alert to liver damage and agranulocytosis. Patients are not allowed to adjust the dosage on their own and need to regularly review thyroid function and blood routine. For hyperthyroidism during pregnancy, the pros and cons should be weighed under the guidance of an endocrinologist. In addition, medicines need to be kept sealed and protected from light to prevent them from becoming ineffective due to moisture. Through rational medication use and monitoring, PTU can effectively control the symptoms of hyperthyroidism and improve patients' quality of life.

Citing sources

1. Literature: "Guidelines for the Diagnosis and Treatment of Thyroid Diseases in China" (Endocrinology Branch of the Chinese Medical Association) 2. Manufacturer: Shanghai Fosun Pharmaceutical (trade name: Propylthiouracil Tablets), Guangzhou Baiyunshan Pharmaceutical 3. Pharmacological data reference: Goodman & Gilman's "Basics of Pharmacology" 12th edition